Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥519.6bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥648.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥491.7bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥29.5bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥27.4bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥29.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥34.7bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥28.0bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥29.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥27.9bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥20.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥23.9bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥19.0bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥20.4bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥19.0bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥353.5bnat 2022-12-31Cons.Assets
Total assets¥325.8bnat 2022-03-31Cons.Assets
Total assets¥321.9bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥122.5bnat 2022-12-31Cons.Liabilities
Total liabilities¥105.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥230.9bnat 2022-12-31Cons.Net assets
Net assets / equity¥220.6bnat 2022-03-31Cons.Net assets
Net assets / equity¥215.8bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥84.8bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥89.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥174.172022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.362022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥204.022021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥162.552021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥56.012021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥174.162022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥204.012021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥162.542021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio65.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio67.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio67.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥37.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥37.8bn
jpcrp040300-q3r_E03226-000Discount Storereportable segmentrevenue2022-04-01 → 2022-12-31¥218.0bn
jpcrp040300-q3r_E03226-000Discount Storereportable segmentrevenue external2022-04-01 → 2022-12-31¥218.0bn
jpcrp040300-q3r_E03226-000Discount Storereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥8m
jpcrp040300-q3r_E03226-000Discount Storereportable segmentsegment profit2022-04-01 → 2022-12-31¥10.8bn
jpcrp040300-q3r_E03226-000Drug Storereportable segmentrevenue2022-04-01 → 2022-12-31¥339.3bn
jpcrp040300-q3r_E03226-000Drug Storereportable segmentrevenue external2022-04-01 → 2022-12-31¥301.5bn
jpcrp040300-q3r_E03226-000Drug Storereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥37.8bn
jpcrp040300-q3r_E03226-000Drug Storereportable segmentsegment profit2022-04-01 → 2022-12-31¥18.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥557.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥519.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥37.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥29.5bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥35.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥35.0bn
jpcrp040300-q3r_E03226-000Discount Storereportable segmentrevenue2021-04-01 → 2021-12-31¥203.6bn
jpcrp040300-q3r_E03226-000Discount Storereportable segmentrevenue external2021-04-01 → 2021-12-31¥203.6bn
jpcrp040300-q3r_E03226-000Discount Storereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥9m
jpcrp040300-q3r_E03226-000Discount Storereportable segmentsegment profit2021-04-01 → 2021-12-31¥9.5bn
jpcrp040300-q3r_E03226-000Drug Storereportable segmentrevenue2021-04-01 → 2021-12-31¥323.1bn
jpcrp040300-q3r_E03226-000Drug Storereportable segmentrevenue external2021-04-01 → 2021-12-31¥288.1bn
jpcrp040300-q3r_E03226-000Drug Storereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥35.0bn
jpcrp040300-q3r_E03226-000Drug Storereportable segmentsegment profit2021-04-01 → 2021-12-31¥17.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥526.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥491.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥35.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥27.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 336
ItemContextValueUnit
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration16000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration11000000JPY
Other comprehensive incomePrior1YTDDuration318000000JPY
Other comprehensive incomeCurrentYTDDuration176000000JPY
Comprehensive incomePrior1YTDDuration19323000000JPY
Comprehensive incomeCurrentYTDDuration20540000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration19323000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration20540000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E03226-000DrugStoreReportableSegmentsMember288108000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E03226-000DiscountStoreReportableSegmentsMember203550000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember491659000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration491659000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E03226-000DrugStoreReportableSegmentsMember35031000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E03226-000DiscountStoreReportableSegmentsMember9000000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember35040000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-35040000000JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E03226-000DrugStoreReportableSegmentsMember323140000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E03226-000DiscountStoreReportableSegmentsMember203559000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember526700000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-35040000000JPY
Net salesPrior1YTDDuration491659000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E03226-000DrugStoreReportableSegmentsMember17920000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E03226-000DiscountStoreReportableSegmentsMember9520000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember27441000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-JPY
Operating incomePrior1YTDDuration27441000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E03226-000DrugStoreReportableSegmentsMember301546000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E03226-000DiscountStoreReportableSegmentsMember218006000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember519553000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration519553000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E03226-000DrugStoreReportableSegmentsMember37780000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E03226-000DiscountStoreReportableSegmentsMember8000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember37789000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-37789000000JPY
Transactions with other segmentsCurrentYTDDuration-JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E03226-000DrugStoreReportableSegmentsMember339327000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E03226-000DiscountStoreReportableSegmentsMember218015000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember557342000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-37789000000JPY
Net salesCurrentYTDDuration519553000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E03226-000DrugStoreReportableSegmentsMember18663000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E03226-000DiscountStoreReportableSegmentsMember10829000000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember29493000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-JPY
Operating incomeCurrentYTDDuration29493000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass